Search results for "Antidepressants"
Recalls, research for generic drug safety
Probable carcinogens have been found in angiotensin-receptor blockers, but experts say generic drugs remain safe overall.
https://immattersacp.org/archives/2020/01/recalls-research-for-generic-drug-safety.htm
1 Jan 2020
IDSA offers guidance on managing drug interactions with nirmatrelvir/ritonavir
The Infectious Diseases Society of America (IDSA) listed six steps to help clinicians prescribe the COVID-19 medication while minimizing interaction risks. Other recent research looked at neuropsychiatric conditions after COVID-19 and hospital profits during the pandemic.
https://immattersacp.org/weekly/archives/2022/05/17/2.htm
17 May 2022
High-value management of patients with GI symptoms
Gastroesophageal reflux disease, rectal bleeding, and chronic diarrhea can be controlled better by applying high-value care.
https://immattersacp.org/archives/2017/06/gastro.htm
1 Jun 2017
Regulatory changes for COVID-19 vaccine; data on waning immunity, outpatient therapies
The FDA authorized vaccinating children, the NIH supported concurrent use of flu and COVID-19 shots, and the CDC addressed a fourth dose of COVID-19 vaccine for the immunocompromised. Trials found benefit from a new monoclonal antibody and an old antidepressant for high-risk outpatients.
https://immattersacp.org/weekly/archives/2021/11/02/1.htm
2 Nov 2021
Warning on medication confusion, recalls due to sterility
This update covers possible confusion between an antidepressant and an anti-clotting drug, as well as 2 sterility warnings.
https://immattersacp.org/archives/2015/10/fda.htm
1 Oct 2015
Daily low-dose aspirin associated with falls in healthy older people
A substudy of a randomized controlled trial found no improvement in risk for first fracture but a higher risk for serious falls in healthy patients ages 70 years and older taking 100 mg of aspirin per day versus those who were not.
https://immattersacp.org/weekly/archives/2022/11/15/1.htm
15 Nov 2022
MKSAP Quiz: Routine follow-up appointment with schizophrenia
A 56-year-old man is evaluated during a routine follow-up appointment. He has schizophrenia treated with olanzapine. Currently, the patient experiences no hallucinations or delusions. He is otherwise healthy. Following a physical exam, what should also be monitored in this patient?
https://immattersacp.org/weekly/archives/2021/10/26/3.htm
26 Oct 2021
Post-COVID-19 clinic director offers tips on lingering symptoms
The first step to treating patients with postacute sequelae of SARS-CoV-2 (PASC) is simple, one expert said: Believe them.
https://immattersacp.org/archives/2022/06/post-covid-19-clinic-director-offers-tips-on-lingering-symptoms.htm
1 Jun 2022
Figure 2. Management of low back pain (LBP). LBP ...
Acetaminophen. NSAIDs. Skeletal muscle relaxants. Antidepressants (TCA). Benzodiazepines. Tr amadol, opioids. ... No intervention was supported by grade A evidence (good-quality evidence of substantial benefit ). MRI magnetic resonance imaging; NSAIDs nonsteroidal anti-inflammatory drugs; TCA tricyclic antidepressants.
https://immattersacp.org/archives/2013/11/acpi-201311-back-pain_t1.pdf
18 Sep 2013
Managing depression is worth the effort
Depression's impact on health is often profound and far-reaching, potentially equaling that of coronary artery disease. To provide clinicians with guidance on treatment of depression, ACP has released a new clinical practice guideline that underscores the severe burden of depression and outlines viable treatment options for patients.
https://immattersacp.org/archives/2016/05/depression.htm
1 May 2016